Daily research

Thursday, November 12, 2026

Every trading morning Matador ranks the names most likely to move: the catalyst, the options flow behind it, and the risks that could break it.

Market context

12 tickers · published 7:42 AM EST

S&P 500 closed at 7,619 on Wednesday (+1.31%), led by a 25%+ CoreWeave earnings surge that briefly reignited the AI trade. Overnight, Nvidia's CEO crisis hit AH markets hard: NVDA -8-9% AH, NQ futures -0.9%, S&P futures -0.4% at the 5:32am ET check. Dow futures held modestly positive (+0.12%), highlighting the index divergence: mega-cap AI tech drag vs. defensive/value resilience. 10-year yield: 4.99%. 2-year yield: 4.74%. DXY at 102.90-103.02 — highest since April 2025. Gold fell to ~$3,875-3,982 range on hawkish rate expectations. Bitcoin ~$73,400, under pressure from ETF outflows and Fed rate hike re-pricing.

Support7,500
Resistance7,700
VIX18.5
Sector rotation

INFLOWS: Healthcare (LLY +3%+ on China GLP-1 first-mover approval; GLP-1 beneficiaries broadly bid). AI Alternatives (AMD +3%+, AVGO +3%+ on NVDA market share rotation). Industrials/Defense (geopolitical uncertainty bid). Rare Earths (China restricting exports; volumes -8.7% but prices +46% YoY). OUTFLOWS: Nvidia-dependent AI infrastructure (NVDA -7-8%, Intel/Marvell -2-3%). Crypto-linked equities (MSTR -6% on MSCI removal; BTC -0.7%). Nasdaq 100 growth broadly (NQ -0.9%). Consumer Discretionary retailers (macro headwinds, mid/low-income squeeze, tariff margin compression).

Tonight's earnings risk

CSCO, AMAT, CBRS, NU

Geopolitical headlines

  • •Nvidia CEO Jensen Huang faces imminent ouster by board after dual extramarital affair allegations — including one woman suspected by US intelligence of being a Chinese spy — triggering a governance crisis that sent NVDA -8% AH and NQ futures -0.9% premarket. National security implications for AI chip exports to China compound the market risk.
  • •Strait of Hormuz: Oil markets on a two-way tape as VP Vance weighs meeting Iranian top official (bearish oil), while IRGC reported explosions affecting two tankers in the Strait this morning (bullish oil). Iran's Parliament Speaker declared the Strait will 'never return to pre-war status,' keeping supply-risk premium alive.
  • •Ukraine launched a 627-drone deep-strike wave that ignited a fire at Russia's primary Baltic Sea oil export terminal at Ust-Luga. Abu Dhabi Ukraine-Russia talks produced a POW swap agreement but zero territorial compromise. Trump administration reportedly considering easing Russia shadow-fleet tanker sanctions to suppress domestic diesel prices.

Upcoming events

  • •08:30 ET — Initial Jobless Claims (week to Nov 7); consensus 195K vs prior 189K
  • •10:00 ET — Existing Home Sales (October); consensus 3.9M annualized
  • •10:00–18:30 ET — Six Fed speakers: Hammack (voter), Barr (voter), Goolsbee, Daly, Schmid, Williams (voter); all scrutinized for 50bp vs 25bp December hike signals post-hot CPI
  • •12:00 ET — EIA Weekly Petroleum Status Report (delayed from Veterans Day)
  • •13:00 ET — 30-year T-Bond Auction; risk event with 10-year yield at 4.99%
  • •16:30 ET — Cisco (CSCO) Q1 FY2027 Earnings Call (reports AMC tonight)
  • •16:30 ET — Applied Materials (AMAT) Q4 FY2026 Earnings Call (reports AMC tonight)
  • •17:00 ET — Cerebras (CBRS) Q3 2026 Earnings Call (reports AMC tonight)
  • •FRIDAY Nov 13 — October PPI (08:30 ET); critical after hot CPI; a hot print could shift December hike debate to 50bp
  • •NEXT WEEK — Nvidia Q3 Earnings (Nov 17 AMC); Jensen Huang House briefing (Nov 18); Anthropic IPO expected (Thanksgiving week); APEC Shenzhen summit Nov 18-19 with Trump-Xi meeting

Hot themes

  • •AI Governance Risk / Nvidia CEO Crisis: The dominant narrative today. Jensen Huang's potential ouster by the Nvidia board — triggered by dual affair allegations including a suspected Chinese spy — creates the largest single-stock governance event in AI history. The CUDA ecosystem's future without Huang is the existential question.
  • •GLP-1 Drugs / Oral Obesity Race: Eli Lilly became the first drugmaker to win China NMPA approval for an oral GLP-1 weight-loss drug (orforglipron/Muyouda), gaining first-mover advantage in the world's largest overweight population (500M+ adults). Novo Nordisk has no equivalent Chinese approval yet.
  • •Fed Hawkishness / Inflation Re-pricing: October CPI came in hot (+0.4% m/m headline, +0.3% core vs +0.2% expected), cementing a December rate hike as near-certainty (90.8% odds of 25bp; 9.2% odds of 50bp). Fed Governor Waller put 50bp on the table. Tomorrow's PPI is the next live catalyst for the sizing debate.

Risk flags

Nvidia Governance Contagion

Board decision on Jensen Huang creates asymmetric sector-wide risk; a chaotic ouster without named successor could trigger NQ -3%+ and a broad AI infrastructure repricing, pulling CRWV, AMD, AVGO, MU all lower regardless of their own fundamentals.

50bp December Fed Hike Risk

October CPI at +0.4% m/m converted December from debate to sizing question; Governor Waller has put 50bp on the table. Tomorrow's PPI could validate the larger hike scenario, repricing duration-sensitive growth stocks sharply lower.

Strait of Hormuz / Iran Escalation

IRGC reported explosions affecting two tankers in the Strait of Hormuz this morning. Full Hormuz closure or major escalation could spike Brent crude +10-15%, reigniting inflation and pressuring the Fed toward even more aggressive tightening.

30-Year T-Bond Auction Tail Risk

With cash bonds re-opening after Veterans Day and 10-year at 4.99%, a weak 30-year auction demand today (1pm ET) could push long yields through 5%, triggering a fresh duration-sensitive growth stock sell-off into the close.

MSTR / Crypto Treasury Forced Selling Cascade

JPMorgan estimates MSTR passive outflows could reach $8.8B if other index providers (S&P, Russell) follow MSCI's lead. The financing flywheel that allowed MSTR to buy Bitcoin by issuing shares at a NAV premium is now under structural pressure.

Anthropic IPO Timing Risk

Some investors now call the $1.5T valuation a 'stretch,' suggesting $1-1.25T is more realistic. If the AI trade deteriorates further on the NVDA crisis, the Thanksgiving-week IPO timing could be pushed or priced down sharply, disappointing GOOGL and AMZN anchor investors.

USD/JPY 160.00 Intervention Trigger

USDJPY broke through 159 for the first time since early September; the 160 level is a known Bank of Japan intervention trigger. A sudden yen intervention could trigger sharp cross-asset volatility and a brief risk-off spike across equities and commodities.

#01

AMAT

Applied Materials Inc.

9.1Alpha
Earnings AMCBullish

Applied Materials reports fiscal Q4 2026 after the close tonight with consensus EPS of $4.06 on $10.3B revenue — implying 87% EPS growth and 51% revenue growth YoY. Options are pricing a 10.2% move vs a 6.5% ten-year historical average, making IV rich. AI chip equipment demand (HBM tools, Blackwell-era tooling) is the key story; memory tool revenue surged 52% last quarter. Strategy: sell elevated IV via iron condor or use a bull call spread if directionally biased.

  • ›Options pricing a 10.2% move post-earnings vs. 6.5% ten-year historical average — IV is rich; premium sellers have structural edge if the actual move stays inside the implied range.
  • ›Applied Materials guided Q4 revenue to $10.25B ±$500M vs $6.8B a year ago — a 51% guided growth rate; memory tool sales grew 52% YoY last quarter including HBM packaging tools.
  • ›Trades at ~18x forward earnings, cheapest of the four major chip equipment makers, providing a valuation cushion vs Lam and ASML. Evercore ISI and RBC Capital both hold Outperform ratings.
  • ›NVDA-sector headwinds today could weigh on the opening print regardless of a strong beat — monitor for sell-the-news risk even on a beat.

Flow Pre-earnings strangle buying active across Nov 14 expiry; IV at 92nd percentile; premium sellers beginning to emerge at the wings; high OI concentration at ATM strikes.

⚠ IV crush post-earnings could wipe 40%+ of option premium overnight — avoid plain vanilla long straddles; prefer spreads to cap premium exposure.

Trade idea for AMAT is for Matador members
Impl Move ±10.2%
IV Rank 92
Rel Vol 2.5×
Short 2.5%
Liquidity tight
Earnings 11/12 AMC
#02

LLY

Eli Lilly and Company

8.9Alpha
Regulatory ApprovalBullish

China's NMPA approved Eli Lilly's orforglipron (branded 'Muyouda') for weight management on Nov. 12 — making Lilly the first drugmaker with an oral GLP-1 drug approved in China, ahead of Novo Nordisk, Pfizer, and local players. China has 500M+ overweight adults and 65%+ obesity prevalence projected by 2030. LLY shares up +3%+ premarket, approaching all-time highs. IV is not elevated (48th percentile), making long premium structures attractive on this fresh catalyst.

  • ›First-mover advantage in the world's second-largest pharmaceutical market; Novo Nordisk's oral Wegovy has NOT received Chinese approval yet, giving LLY a time advantage to lock in distribution channels and prescription volume.
  • ›China has 500M+ overweight or obese adults — the world's largest such population — with prevalence projected to exceed 65% of adults by 2030, representing a multi-hundred-billion-dollar TAM for GLP-1 drugs.
  • ›Lilly committed $3 billion over 10 years to China supply chain (Suzhou and Beijing manufacturing expansions), signaling deep commercial conviction. A type 2 diabetes application for orforglipron is also under NMPA review.
  • ›IV at only 48th percentile — a fresh non-earnings catalyst with low implied volatility creates ideal conditions for buying premium (long calls or call spreads) vs. selling premium.

Flow Aggressive call sweeps on Nov 21 and Dec 19 expiries; $1480 and $1510 strike calls most active; ATM straddle bid up ~15% intraday on approval news.

⚠ China pricing and national reimbursement negotiations could stretch commercial uptake timeline by 12-18 months; self-pay market caps near-term TAM relative to US experience.

Trade idea for LLY is for Matador members
Impl Move ±3.5%
IV Rank 48
Rel Vol 3.2×
Short 1.0%
Liquidity tight
#03

NVDA

Nvidia Corporation

8.7Alpha
Governance Crisis / CEO Ouster RiskBearish

Nvidia's board met Wednesday to decide whether to oust founder CEO Jensen Huang following reports of two extramarital affairs — including one with a woman suspected of being a Chinese intelligence operative. NVDA is -6-8% premarket. Bernstein downgraded to Market Perform (target: $200), Oppenheimer and William Blair also downgraded. Dan Ives values NVDA at $300 with Jensen and $225 without. The stock has shed ~$600B in market cap since the investigation launched. Earnings still pending Nov 17 AMC, and Jensen has been summoned to a House briefing Nov 18. IV is at 90th percentile — prefer defined-risk structures.

  • ›Board is working with an outside firm to find a potential successor; no named internal candidate identified — Nvidia's annual filing acknowledged it is 'highly dependent on the services of its longstanding executive team,' making succession a core risk.
  • ›Four analyst downgrades in two days (Bernstein to Market Perform / $200 target; Oppenheimer to Perform; William Blair to Market Perform; Baird cut visibility); Raymond James lone Strong Buy reiteration at $515.
  • ›National security dimension: Senators Warren and Coons wrote to Commerce Department to preserve records on Nvidia AI chip exports to China; DOJ Megaspeed probe of a Singapore firm suspected of funneling NVDA chips to China adds regulatory overhang.
  • ›NVDA reports Q3 FY2027 on Nov 17 AMC — a binary event within 5 days. Fundamentals (Blackwell demand, $132.5B CRWV backlog as customer) remain strong; the market is pricing a governance discount on top of earnings risk.

Flow Heavy put sweeps across Nov/Dec expiries; $160 and $155 puts most active; call sellers dominating flow; put/call ratio at 2.3×; call spread sellers active above $175.

⚠ Options IV at 90th percentile; a resolution (Huang stays with governance reforms) could trigger a violent short-squeeze and 15%+ upside reversal. Do NOT sell uncovered puts into the Nov 17 earnings binary.

Trade idea for NVDA is for Matador members
Impl Move ±12.0%
IV Rank 90
Rel Vol 4.5×
Short 1.5%
Liquidity tight
Earnings 11/17 AMC
#04

AMD

Advanced Micro Devices Inc.

8.3Alpha
Beneficiary Rotation / Analyst UpgradeBullish

AMD is +3%+ premarket as the primary direct AI accelerator beneficiary of Nvidia's leadership crisis. William Blair upgraded AMD the same day, naming it alongside Marvell and Broadcom as perceived beneficiaries of any NVDA customer dislocation. AMD's Instinct GPU lineup competes directly with NVDA in AI training/inference. Analyst consensus target of $652 implies ~18% upside. The bull case: hyperscalers diversify AI stack away from NVDA concentration risk.

  • ›William Blair upgraded AMD citing Nvidia governance risk as a catalyst for customer procurement diversification; Oppenheimer also named AMD, Marvell, and Broadcom as 'perceived beneficiaries of any Nvidia dislocation.'
  • ›AMD competes directly with Nvidia through its Instinct AI accelerators, giving data-center customers another option for AI workloads; Helios platform expected to ramp through 2027.
  • ›AMD carries Strong Buy consensus on TipRanks with an average analyst target of $652.18, suggesting ~18% upside from current levels; both AMD and Broadcom are strong buys.
  • ›Risk: Customer switching from Nvidia's CUDA ecosystem is slow and costly — platform migration demands software adaptation and months of system redeployment; market share gains are a 2027+ story, not 2026.

Flow Call sweeps on Nov 21 and Dec 19 expiries; $560 and $580 calls most active; implied skew turned bullish vs. yesterday's neutral reading; large block call buyers emerging.

⚠ AMD's premarket move is driven by narrative rotation, not fundamental business wins — a resolution of NVDA's CEO crisis or Huang staying on could quickly reverse the AMD premium.

Trade idea for AMD is for Matador members
Impl Move ±8.0%
IV Rank 68
Rel Vol 3.0×
Short 3.0%
Liquidity tight
#05

CSCO

Cisco Systems Inc.

8.0Alpha
Earnings AMCNeutral

Cisco reports Q1 FY2027 results after the close tonight (call 4:30pm ET). Guidance was $18.0-18.2B revenue and EPS $1.32-$1.34. Consensus implies 22% revenue growth and 32-33% EPS growth YoY. Options price ±8.88% vs a typical ~4.8% median move historically. The key watch: AI infrastructure order rate (targeting $7.5B in FY2027 vs $4B in FY2026) and gross margins (fell 2.1pp last quarter on hardware mix shift). Stock down 14.7% over last 20 sessions — the bar is lowered.

  • ›Cisco expects $7.5 billion of AI infrastructure revenue from hyperscalers in fiscal 2027, up from $4 billion in fiscal 2026 — the sequential AI order rate is the most market-moving line item.
  • ›Options price ±8.88% move post-earnings vs typical ~4.8% median move historically — IV is rich; the implied move significantly overprices the historical reaction, favoring premium-selling structures.
  • ›Stock is down 14.7% over the last 20 sessions and 20.5% below its August earnings-day close — bar is meaningfully lowered going in, reducing downside miss risk.
  • ›Historical Q1 fiscal reporting (November) has the weakest median next-day performance of Cisco's four reporting months: -2.1% median — be cautious on pure directional bullish bets.

Flow High OI concentration at ATM strikes; some call spread buyers from AI optimists; IV at 85th percentile signals premium sellers are active; Nov 14 strangle OI elevated.

⚠ Non-GAAP gross margin degradation was the key post-earnings selloff trigger last quarter; watch closely in tonight's print against the 65-66% guidance. Any margin miss will override the AI order growth narrative.

Trade idea for CSCO is for Matador members
Impl Move ±8.9%
IV Rank 85
Rel Vol 2.0×
Short 1.5%
Liquidity tight
Earnings 11/12 AMC
#06

AVGO

Broadcom Inc.

7.8Alpha
Beneficiary Rotation — Custom AI Chips + NetworkingBullish

Broadcom +3%+ premarket as NVDA's crisis drives hyperscalers to accelerate diversification into custom AI silicon (TPUs, ASICs) and networking. AVGO's value proposition is distinct from AMD — switching friction is lower for networking and custom chip design than for GPU compute. Hyperscalers (Google TPU, Meta MTIA) are AVGO customers for custom AI chips. Bloomberg Analyst consensus target of $524 implies 51.79% upside.

  • ›Nvidia's rivals don't need to replace NVDA chips one-for-one — networking and custom AI silicon design have lower switching friction; AVGO gains as hyperscalers re-balance AI stacks and expand interconnect capacity.
  • ›Broadcom carries Strong Buy consensus with average analyst target of $524, implying 51.79% upside from current levels — the largest upside of any name on this watchlist.
  • ›Anna Wu of Floodlines Research: 'Huang's scandal has raised public doubts about Nvidia's commercial secrets and product edge — Broadcom in the custom chip/networking space is a natural beneficiary.'
  • ›Alphabet announced plans to roll out a broader array of AI TPU chips, aiming to capitalize on its rapid rise as a Nvidia challenger — AVGO is a key design partner in this buildout.

Flow Call sweeps on Dec/Jan expiries as beneficiary trade is established; implied skew mildly bullish; large block call buyers in Dec 19 expiry at 3-5% OTM strikes.

⚠ AVGO's premarket premium is a derivative of NVDA's crisis; if Huang situation resolves favorably, the beneficiary trade reverses quickly. Also watch hyperscaler capex cuts (negative FCF at AMZN/GOOGL) as a tail risk.

Trade idea for AVGO is for Matador members
Impl Move ±7.0%
IV Rank 62
Rel Vol 2.5×
Short 2.0%
Liquidity tight
#07

MSTR

Strategy Inc. (MicroStrategy)

7.4Alpha
MSCI Index Removal — Forced Passive SellingBearish

MSCI confirmed Strategy's removal from its global equity indexes (MSCI USA, MSCI World) effective after the close on November 30. Passive funds must sell their MSTR holdings by that date — estimated $1.4-2.8B in forced sales. MSTR is -6% premarket at $114.86. The financing flywheel (issuing shares at NAV premium to buy Bitcoin) is structurally impaired. Bitcoin also -0.7% at ~$73,400 on Fed hawkishness. High short interest (~25%) creates squeeze risk on any reversal.

  • ›MSCI confirmed MSTR removal from MSCI USA Index effective November 30 under new 'non-operating entity' rules; Strategy failed four of five financial ratio tests after already failing two consecutive annual screens.
  • ›JPMorgan estimates total outflows could reach $8.8 billion if other major index providers (S&P, Russell) follow MSCI's lead; MSTR itself flagged ~$2.8B in estimated passive selling in SEC filings.
  • ›The share-issuance-at-NAV-premium financing flywheel is now structurally impaired: index removal reduces institutional demand, compressing the premium that allowed MSTR to issue shares to buy Bitcoin at favorable terms.
  • ›Bitcoin held by MSTR (850,364 BTC at avg cost $75,456) is NOT required to be sold by MSCI rules; the forced selling is equity, not Bitcoin — but equity pressure weakens MSTR's future Bitcoin accumulation capacity.

Flow Heavy put sweeps across Nov/Dec expiries; Dec $110 and $100 puts most active; put/call ratio at 2.1×; some aggressive Dec put spread buyers establishing positions ahead of Nov 30 rebalancing.

⚠ Short interest ~25% creates extreme squeeze risk; a Bitcoin surge above $80K or Saylor buyback announcement could trigger a 15-20% squeeze before Nov 30. Size position with risk management in mind.

Trade idea for MSTR is for Matador members
Impl Move ±8.5%
IV Rank 78
Rel Vol 2.8×
Short 25.0%
Liquidity moderate
#08

CRWV

CoreWeave Inc.

7.1Alpha
Post-Earnings Momentum vs. NVDA Sector HeadwindNeutral

CoreWeave surged +25% Wednesday after reporting Q3 2026 results that blew past estimates: revenue +168% to $3.66B, backlog surged to $132.5B, and full-year guidance raised to $13.0-13.3B. CEO canceled his personal stock-selling plan and pledged no new unsecured debt. Now giving back ~6% premarket on NVDA governance headwinds. The investment-grade loan (~$4B, led by MS/MUFG) is the next key catalyst. High short interest (~18%) + strong fundamentals = squeeze potential on NVDA resolution.

  • ›Q3 revenue +168% to $3.66B beat the $3.54B estimate; backlog rose to $132.5B from $104B; 2026 guidance raised to $13.0-13.3B above the $12.88B consensus; Adjusted operating income $379M vs $200-260M guide.
  • ›CEO Michael Intrator canceled his personal 10b5-1 stock sale plan and said qualified demand is 10× available capacity through 2027; Ampere/Hopper GPU pricing rose 30-50% QoQ, confirming supply-demand tightness.
  • ›CoreWeave is preparing an investment-grade loan of at least $4B led by Morgan Stanley and Mitsubishi UFJ; if successfully syndicated, it cuts borrowing costs vs high-yield debt and reduces refinancing risk.
  • ›NVDA is set to invest up to $10B in Anthropic (a key CRWV customer ecosystem); Jensen Huang's crisis creates uncertainty for CRWV's strategic partner relationship, hence today's -6% giveback.

Flow Post-earnings call buyers dominant: 7,500 Jun 2027 $70 calls bought for ~$9.4M; put sellers covering; overall flow 3.2× bullish by premium. Put sales doubled on Nov 11 to $12M as holders covered short positions.

⚠ CRWV has $50B+ in total debt with unsecured notes at distressed yields; the investment-grade loan must succeed to validate the funding model. Failure to syndicate would be a major negative catalyst.

Trade idea for CRWV is for Matador members
Impl Move ±15.0%
IV Rank 85
Rel Vol 4.0×
Short 18.0%
Liquidity moderate
#09

MU

Micron Technology Inc.

6.8Alpha
AI Memory Demand RetracementNeutral

Micron surged +11.9% Wednesday to $811.30 on the CoreWeave earnings-driven AI memory demand optimism (HBM/DRAM tools for AI accelerators). Now giving back as NVDA sector headwinds spread across the chip complex; premarket quotes testing $777.89 key support. MU stalled at $817.65 where a falling trendline meets the 50% Fibonacci retracement. No company-specific catalyst today — this is a pure sector rotation and technical setup play.

  • ›MU rebounded 11.89% to $811.30 Wednesday but stalled exactly at $817.65 — a falling trendline intersecting the 50% Fibonacci retracement — a technically significant resistance level.
  • ›AI memory demand from HBM (High Bandwidth Memory) used in NVIDIA Blackwell and AMD Instinct AI accelerators drove the rally; AMAT reported memory tool sales grew 52% YoY last quarter.
  • ›Micron's HBM3E capacity is sold out through fiscal 2025; AI server buildout from hyperscalers creates multi-year structural demand for advanced memory.
  • ›NVDA headwinds today pushed Micron premarket -2% per Reuters data; watch $777.89 support — a close below opens downside to $750 area.

Flow Mixed flow; put/call ratio near 1.0 as market digests the reversal; some defensive put spread buying at $780/$760; large call positions from Wednesday's rally are being partially hedged.

⚠ No company-specific catalyst today; MU is a derivative play on overall AI semiconductor sentiment. A major NVDA resolution or further crisis escalation will dominate MU's intraday direction more than any fundamental driver.

Trade idea for MU is for Matador members
Impl Move ±7.5%
IV Rank 72
Rel Vol 3.0×
Short 3.0%
Liquidity tight
#10

GOOGL

Alphabet Inc.

6.6Alpha
NVDA Beneficiary + Anthropic IPO AnchorBullish

Alphabet is a double-layered beneficiary: (1) TPU custom AI chips as NVDA alternatives for hyperscalers, and (2) $10B anchor investor in Anthropic's upcoming IPO (expected Thanksgiving week). GOOGL gained modestly in AH on the NVDA crisis. Google Cloud revenue grew 82% YoY to $24.77B in Q2 — an independent bull case beyond the NVDA crisis narrative.

  • ›Alphabet's TPUs are custom-built for AI — 'AMD as a direct competitor and Alphabet and Broadcom in the TPU space are natural beneficiaries in the short term,' said Anna Wu of Floodlines Research.
  • ›Alphabet is set to invest $10B in Anthropic through a private placement ahead of the IPO (Thanksgiving week), matched only by Nvidia's planned $10B investment; NVDA governance crisis could make Alphabet's anchor role more critical.
  • ›Google Cloud revenue grew 82% to $24.77B in Q2 2026 — independent of the Anthropic IPO, providing a separate and standalone valuation driver.
  • ›Anthropic IPO underwriters considering $1.5T+ valuation amid unusually strong investor demand; successful IPO pricing would generate large paper gains on GOOGL's balance sheet and boost reported EPS via mark-to-market.

Flow Call spread accumulation in Dec/Jan expiries; implied skew mildly bullish; large OI at ATM strikes; institutional call spread buyers at ~3-5% OTM Dec strikes.

⚠ GOOGL's upside is contingent on NVDA crisis sustaining — a quick resolution (Huang stays) fades the beneficiary premium. Anthropic IPO valuation debate ($1T-$1.5T range) adds uncertainty to the balance sheet gain.

Trade idea for GOOGL is for Matador members
Impl Move ±4.0%
IV Rank 42
Rel Vol 1.8×
Short 0.8%
Liquidity tight
#11

NBIS

Nebius Group N.V.

6.3Alpha
Earnings BMONeutral

Nebius Group — a European AI cloud infrastructure provider — reported Q3 2026 results before the market open. Options had priced ±13.25% move going into the report. Nebius is an emerging neocloud proxy alongside CoreWeave; smaller cap with thin liquidity. AI cloud demand post-CoreWeave earnings beat is the tailwind; NVDA headwinds and rising rates are headwinds for the leveraged neocloud model broadly.

  • ›Options priced ±13.25% move ahead of the BMO earnings release — the third-largest implied move on today's earnings calendar.
  • ›Nebius is an AI cloud infrastructure provider focused on the European market; emerging as a comparable to CoreWeave but with smaller scale and less established financing.
  • ›CoreWeave's strong Q3 beat (revenue +168%, backlog $132.5B) set a bullish sector tone that could lift NBIS expectations; however NVDA governance crisis weighs on the AI infrastructure group.
  • ›Options liquidity is thinner than mega-cap names — wide bid-ask spreads in weeklies; check OI and spreads before executing. Size accordingly relative to trading capacity.

Flow Straddle buyers into earnings; volume 3.5× average on thin OI base; now post-print, flow depends on actual result quality; verify spreads before any trade.

⚠ Very small-cap AI cloud name with limited options OI and wide spreads; execution risk is high. Neocloud sector broadly under pressure from rising rates (10-year at 4.99%) and NVDA governance headwinds.

Trade idea for NBIS is for Matador members
Impl Move ±13.3%
IV Rank 80
Rel Vol 3.5×
Short 8.0%
Liquidity moderate
Earnings 11/12 BMO
#12

M

Macy's Inc.

5.6Alpha
Earnings BMOBearish

Macy's reported Q3 2026 results before the open this morning with consensus EPS estimate of -$0.18. The retailer faces macro headwinds: middle-and-lower-income shoppers pulling back, store traffic declining, tariff-related margin compression, and rising credit card delinquencies. High short interest (~12%) creates squeeze potential if the actual result surprises to the upside vs the deeply negative consensus. Check actual results before trading.

  • ›EPS consensus of -$0.18 reflects deep operational pressure; comparable sales have been declining as middle-income shoppers face budget stress from elevated food/energy prices and rising credit costs.
  • ›Tariff escalation raises input cost and margin pressure for import-heavy retailers; White House adviser Navarro signaled the administration is 'quadrupling down on tariffs' post-midterm elections.
  • ›Short interest of ~12% creates squeeze risk on any upside surprise to the deeply negative consensus — a beat (even a smaller-than-expected loss) could trigger a 10-15% gap higher.
  • ›Sector analog: Kohl's last quarter beat a similarly low bar (EPS $1.28 vs $0.55 estimate, +132% beat) and gapped higher; Macy's could follow the same pattern if actual results outperform the -$0.18 estimate.

Flow Pre-print put buyers dominated flow; now post-print, depending on actual results, flow may shift aggressively. Watch for unusual call volume if stock rips on a beat vs deeply negative consensus.

⚠ Report is already out pre-market — the initial price reaction is already in progress. Check actual results before entering any position. High short interest (~12%) means a beat could ignite a 10-15% squeeze.

Trade idea for M is for Matador members
Impl Move ±6.0%
IV Rank 60
Rel Vol 2.2×
Short 12.0%
Liquidity moderate
Earnings 11/12 BMO

Get the trade on every name

Members see the options structure for each pick, backtest it in one click, and read the full archive.

Disclaimer: This research is compiled from publicly available information for educational and analytical purposes only. It does not constitute investment advice or a recommendation to buy or sell any security. Always conduct your own due diligence.